Current research has also started exploring likely neuroprotective results of GLP-one receptor agonists, with some studies suggesting feasible benefits in conditions like Alzheimer's disease and Parkinson's condition, even though these purposes keep on being investigational at present46.It truly is important to thoroughly talk about these risks wit